Ahmed, Osman
Caravaca, April S.
Crespo, Maria
Dai, Wanmin
Liu, Ting
Guo, Qi
Leiva, Magdalena
Sabio, Guadalupe
Shavva, Vladimir S.
Malin, Stephen G.
Olofsson, Peder S. https://orcid.org/0000-0003-3473-5948
Funding for this research was provided by:
the MedTechLabs (2019)
ALF Project Funds (20170199, 20180502)
Knut och Alice Wallenbergs Stiftelse (2014)
Vetenskapsrådet (2017-03366, 2020-04443, 2020-01645, 2020-01557)
Hjärt-Lungfonden (20200827, 20190672, 2021043122, 20210520, 20210532)
Novo Nordisk postdoctoral fellow program at Karolinska Institutet (2019)
Ministerio de Economía y Competitividad ((MINECO, BES-2017-079711), PMP21/00057)
Fundación AECC PROYE (19047SABI)
Federation of European Biochemical Societies
Karolinska Institute
Article History
Received: 14 February 2023
Accepted: 10 March 2023
First Online: 31 March 2023
Declarations
:
: All procedures with experimental animals were approved by the regional Stockholm Animal Research Ethics Committee (Stockholm, Sweden).
: All coauthors have approved the manuscript.
: PSO is a founder and shareholder of Emune AB. OA is a co-founder and shareholder of Lipoprotein Research Stockholm AB. The remaining authors declare no competing interests.